This is how biotechnology stars are born. We've seen it before many times. Typically a doctor or scientist invents a new technology and teams with a company which has greater resources and contacts to form a new entity. Dr. Norman Marcus and EP Health Sciences appear to be exactly that.
EPGL is tied in with Allied Health Care Professionals, US Military, and many other health institutions. Dr. Norman Marcus is tied in with New York University and Stephens Institute.
The market the MPDD device addresses enormous and even if it takes a small portion of it, EPGL could be monumentally undervalued right here. I don't think we'll be at .0002 by November's WCD conference when Dr. Marcus makes his presentation to the world.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.